Oscar Health, Inc. (NYSE:OSCR) Shares Sold by Gotham Asset Management LLC

Gotham Asset Management LLC trimmed its stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 74.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,032 shares of the company's stock after selling 29,901 shares during the period. Gotham Asset Management LLC's holdings in Oscar Health were worth $135,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. increased its holdings in shares of Oscar Health by 3.2% in the 4th quarter. Vanguard Group Inc. now owns 18,997,973 shares of the company's stock valued at $255,333,000 after acquiring an additional 586,626 shares during the period. Deerfield Management Company L.P. Series C grew its position in Oscar Health by 50.7% during the 4th quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company's stock worth $159,062,000 after purchasing an additional 3,983,325 shares during the last quarter. JPMorgan Chase & Co. increased its stake in Oscar Health by 348.7% in the fourth quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock valued at $139,246,000 after purchasing an additional 8,051,379 shares during the period. Gilder Gagnon Howe & Co. LLC increased its stake in Oscar Health by 51.4% in the fourth quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company's stock valued at $85,154,000 after purchasing an additional 2,151,256 shares during the period. Finally, BIT Capital GmbH raised its holdings in shares of Oscar Health by 5,711.6% in the fourth quarter. BIT Capital GmbH now owns 4,473,853 shares of the company's stock valued at $60,129,000 after buying an additional 4,396,872 shares during the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.

Oscar Health Price Performance

Shares of OSCR traded up $0.72 during mid-day trading on Tuesday, hitting $14.89. The company's stock had a trading volume of 2,825,631 shares, compared to its average volume of 4,306,593. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 1-year low of $11.20 and a 1-year high of $23.79. The firm has a market capitalization of $3.73 billion, a P/E ratio of -745.43 and a beta of 1.75. The firm has a 50-day simple moving average of $13.68 and a 200 day simple moving average of $14.59.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.83 by $0.09. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The firm had revenue of $3 billion during the quarter, compared to analysts' expectations of $2.87 billion. During the same quarter in the prior year, the business posted $0.62 earnings per share. Oscar Health's revenue was up 42.2% compared to the same quarter last year. Analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts recently issued reports on OSCR shares. Wall Street Zen cut Oscar Health from a "buy" rating to a "hold" rating in a research report on Thursday, May 22nd. Wells Fargo & Company downgraded Oscar Health from an "overweight" rating to an "equal weight" rating and lowered their target price for the company from $20.00 to $16.00 in a research note on Thursday, March 13th. Two analysts have rated the stock with a sell rating, three have issued a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, Oscar Health has an average rating of "Hold" and an average price target of $20.08.

Insider Activity at Oscar Health

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the firm's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $16.43, for a total value of $410,750.00. Following the completion of the transaction, the director now directly owns 64,512 shares of the company's stock, valued at $1,059,932.16. This trade represents a 27.93% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 24.39% of the company's stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.